Papillary renal cell carcinoma

1 paper

Trial sponsors

National Cancer Institute
2 trialsPhase 2113 people
Children's Oncology Group
1 trialPhase 2291 people

Latest

1 in 12 months

Preprint15 Jul

Using Artificial Intelligence to Structure Treatment Decisions in a Rare Hereditary Cancer: A Viewpoint on MET-Driven Hereditary Papillary Renal Carcinoma (Preprint)

Preprint: reviewKidney